ipamorelin palo alto Ipamorelin (RUO) | Selective GHS-R1a
Description
2003 Dec;48(12):3419-30
The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
10.1016/j.redox.2020.101442 75
But most of what circulates online comes from animal data, not large, controlled human trials
Journal of Cosmetic Dermatology, 22 (7), 1938-1945
